62 related articles for article (PubMed ID: 11962513)
1. Zampanolide and dactylolide: cytotoxic tubulin-assembly agents and promising anticancer leads.
Chen QH; Kingston DG
Nat Prod Rep; 2014 Sep; 31(9):1202-26. PubMed ID: 24945566
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a des-B-ring bryostatin analogue leads to an unexpected ring expansion of the bryolactone core.
Kraft MB; Poudel YB; Kedei N; Lewin NE; Peach ML; Blumberg PM; Keck GE
J Am Chem Soc; 2014 Sep; 136(38):13202-8. PubMed ID: 25207434
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Several Bryostatin Analogues Bearing a Diacylglycerol Lactone C-Ring.
Baumann DO; McGowan KM; Kedei N; Peach ML; Blumberg PM; Keck GE
J Org Chem; 2016 Sep; 81(17):7862-83. PubMed ID: 27494208
[TBL] [Abstract][Full Text] [Related]
4. Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial.
Bear HD; Roberts J; Cornell D; Tombes MB; Kyle B
Cancer Immunol Immunother; 2001 Jul; 50(5):269-74. PubMed ID: 11499810
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis of bryostatin 16 using a Pd-catalyzed diyne coupling as macrocyclization method and synthesis of C20-epi-bryostatin 7 as a potent anticancer agent.
Trost BM; Dong G
J Am Chem Soc; 2010 Nov; 132(46):16403-16. PubMed ID: 21043491
[TBL] [Abstract][Full Text] [Related]
6. "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo.
DeChristopher BA; Fan AC; Felsher DW; Wender PA
Oncotarget; 2012 Jan; 3(1):58-66. PubMed ID: 22308267
[TBL] [Abstract][Full Text] [Related]
7. Aaptamine-rich Fraction from the Indonesian Marine Sponge, Aaptos suberitoides, Exhibits a Cytotoxic Effect on DLD-1 Colorectal Cancer Cells.
Hardhiyuna M; Arbi UY; Zuraida Z; Ahmadi P
Asian Pac J Cancer Prev; 2024 May; 25(5):1737-1743. PubMed ID: 38809646
[TBL] [Abstract][Full Text] [Related]
8. Synthetic studies of microtubule stabilizing agent peloruside A: an asymmetric synthesis of C
Ghosh AK; Kim JH
Tetrahedron Lett; 2003 Oct; 44(41):7659-7661. PubMed ID: 30443085
[TBL] [Abstract][Full Text] [Related]
9. An enantioselective synthesis of the C
Ghosh AK; Kim JH
Tetrahedron Lett; 2003 May; 44(20):3967-3969. PubMed ID: 30393410
[TBL] [Abstract][Full Text] [Related]
10. Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.
Chan A; Gilfillan C; Templeton N; Paterson I; Northcote PT; Miller JH
Invest New Drugs; 2017 Dec; 35(6):706-717. PubMed ID: 28733703
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.
Chan A; Singh AJ; Northcote PT; Miller JH
Invest New Drugs; 2015 Jun; 33(3):564-74. PubMed ID: 25822110
[TBL] [Abstract][Full Text] [Related]
12. Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.
Ballatore C; Brunden KR; Huryn DM; Trojanowski JQ; Lee VM; Smith AB
J Med Chem; 2012 Nov; 55(21):8979-96. PubMed ID: 23020671
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.
Miller JH; Singh AJ; Northcote PT
Mar Drugs; 2010 Mar; 8(4):1059-79. PubMed ID: 20479967
[TBL] [Abstract][Full Text] [Related]
14. Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.
Wilmes A; Rawson P; Peng L; McLauchlan D; Northcote PT; Jordan TW; Miller JH
Invest New Drugs; 2011 Aug; 29(4):544-53. PubMed ID: 20107863
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis of (-)-2-epi-peloruside A.
Smith AB; Cox JM; Furuichi N; Kenesky CS; Zheng J; Atasoylu O; Wuest WM
Org Lett; 2008 Dec; 10(24):5501-4. PubMed ID: 19007239
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the synthesis of the novel antitumor agent peloruside A.
Williams DR; Nag PP; Zorn N
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):251-71. PubMed ID: 18283613
[TBL] [Abstract][Full Text] [Related]
17. The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C.
Hood KA; Bäckström BT; West LM; Northcote PT; Berridge MV; Miller JH
Anticancer Drug Des; 2001; 16(2-3):155-66. PubMed ID: 11962513
[TBL] [Abstract][Full Text] [Related]
18. Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells.
Miller JH; Rouwé B; Gaitanos TN; Hood KA; Crume KP; Bäckström BT; La Flamme AC; Berridge MV; Northcote PT
Apoptosis; 2004 Nov; 9(6):785-96. PubMed ID: 15505421
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
